4//SEC Filing
Scheessele William John 4
Accession 0001104659-21-126728
CIK 0001818382other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 3:51 PM ET
Size
5.5 KB
Accession
0001104659-21-126728
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Scheessele William John
Chief Commercial Officer
Transactions
- Award
Stock Options (right to buy)
2021-10-13+157,558→ 157,558 totalExercise: $10.03Exp: 2031-10-13→ Common Stock (157,558 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on August 9, 2022, after which 1/36 of the option will become exercisable on the 9th of each month through August 9, 2025.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001879378
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 3:51 PM ET
- Size
- 5.5 KB